vs
Fortress Biotech, Inc.（FBIO）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
REDWOOD TRUST INC的季度营收约是Fortress Biotech, Inc.的1.6倍（$25.9M vs $16.1M），REDWOOD TRUST INC净利率更高（77.2% vs -24.5%，领先101.7%），Fortress Biotech, Inc.同比增速更快（6.3% vs -6.1%），过去两年Fortress Biotech, Inc.的营收复合增速更高（11.0% vs -41.0%）
堡垒生物科技（Fortress Biotech）是一家生物制药企业，核心业务为收购、开发并商业化创新医药与生物技术产品。公司由医学博士林赛·A·罗森瓦尔德担任首席执行官，包括绝大多数子公司在内，公司总部均设于佛罗里达州贝港群岛。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
FBIO vs RWT — 直观对比
营收规模更大
RWT
是对方的1.6倍
$16.1M
营收增速更快
FBIO
高出12.3%
-6.1%
净利率更高
RWT
高出101.7%
-24.5%
两年增速更快
FBIO
近两年复合增速
-41.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.1M | $25.9M |
| 净利润 | $-3.9M | $20.0M |
| 毛利率 | 66.1% | — |
| 营业利润率 | -28.8% | — |
| 净利率 | -24.5% | 77.2% |
| 营收同比 | 6.3% | -6.1% |
| 净利润同比 | 41.8% | 402.6% |
| 每股收益（稀释后） | $-0.15 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FBIORWT
| Q4 25 | $16.1M | $25.9M | ||
| Q3 25 | $17.6M | $15.0M | ||
| Q2 25 | $16.4M | $13.8M | ||
| Q1 25 | $13.1M | $27.9M | ||
| Q4 24 | $15.1M | $27.6M | ||
| Q3 24 | $14.6M | $25.5M | ||
| Q2 24 | $14.9M | $67.4M | ||
| Q1 24 | $13.0M | $74.5M |
净利润FBIORWT
| Q4 25 | $-3.9M | $20.0M | ||
| Q3 25 | $5.8M | $-7.7M | ||
| Q2 25 | $15.5M | $-98.5M | ||
| Q1 25 | $-10.6M | $16.1M | ||
| Q4 24 | $-6.8M | $-6.6M | ||
| Q3 24 | $-12.9M | $14.8M | ||
| Q2 24 | $-10.9M | $15.5M | ||
| Q1 24 | $-15.4M | $30.3M |
毛利率FBIORWT
| Q4 25 | 66.1% | — | ||
| Q3 25 | 67.4% | — | ||
| Q2 25 | 69.9% | — | ||
| Q1 25 | 63.5% | — | ||
| Q4 24 | 69.1% | — | ||
| Q3 24 | 69.4% | — | ||
| Q2 24 | 61.6% | — | ||
| Q1 24 | 53.9% | — |
营业利润率FBIORWT
| Q4 25 | -28.8% | — | ||
| Q3 25 | -38.6% | -9.0% | ||
| Q2 25 | -222.2% | -679.0% | ||
| Q1 25 | -169.9% | 80.2% | ||
| Q4 24 | -158.3% | -1.3% | ||
| Q3 24 | -151.0% | 86.1% | ||
| Q2 24 | -186.5% | 30.3% | ||
| Q1 24 | -280.6% | 41.3% |
净利率FBIORWT
| Q4 25 | -24.5% | 77.2% | ||
| Q3 25 | 33.2% | -51.4% | ||
| Q2 25 | 94.4% | -712.0% | ||
| Q1 25 | -80.6% | 57.8% | ||
| Q4 24 | -44.7% | -24.0% | ||
| Q3 24 | -88.0% | 58.1% | ||
| Q2 24 | -73.5% | 23.0% | ||
| Q1 24 | -118.3% | 40.6% |
每股收益（稀释后）FBIORWT
| Q4 25 | $-0.15 | $0.11 | ||
| Q3 25 | $0.11 | $-0.08 | ||
| Q2 25 | $0.45 | $-0.76 | ||
| Q1 25 | $-0.48 | $0.10 | ||
| Q4 24 | $-0.16 | $-0.08 | ||
| Q3 24 | $-0.76 | $0.09 | ||
| Q2 24 | $-0.73 | $0.10 | ||
| Q1 24 | $-1.04 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $79.4M | $255.7M |
| 总债务越低越好 | $52.4M | — |
| 股东权益账面价值 | $49.9M | $982.6M |
| 总资产 | $185.5M | $23.7B |
| 负债/权益比越低杠杆越低 | 1.05× | — |
8季度趋势，按日历期对齐
现金及短期投资FBIORWT
| Q4 25 | $79.4M | $255.7M | ||
| Q3 25 | $86.2M | $226.3M | ||
| Q2 25 | $74.4M | $302.0M | ||
| Q1 25 | $91.3M | $259.9M | ||
| Q4 24 | $57.3M | $245.2M | ||
| Q3 24 | $58.9M | $253.7M | ||
| Q2 24 | $76.2M | $275.6M | ||
| Q1 24 | $83.8M | $275.4M |
总债务FBIORWT
| Q4 25 | $52.4M | — | ||
| Q3 25 | $47.8M | — | ||
| Q2 25 | $50.0M | — | ||
| Q1 25 | $56.4M | — | ||
| Q4 24 | $58.0M | — | ||
| Q3 24 | $52.5M | — | ||
| Q2 24 | $67.0M | — | ||
| Q1 24 | $61.4M | $1.7B |
股东权益FBIORWT
| Q4 25 | $49.9M | $982.6M | ||
| Q3 25 | $55.9M | $999.0M | ||
| Q2 25 | $43.9M | $1.1B | ||
| Q1 25 | $22.3M | $1.2B | ||
| Q4 24 | $22.7M | $1.2B | ||
| Q3 24 | $21.2M | $1.2B | ||
| Q2 24 | $17.9M | $1.2B | ||
| Q1 24 | $23.0M | $1.2B |
总资产FBIORWT
| Q4 25 | $185.5M | $23.7B | ||
| Q3 25 | $181.4M | $22.6B | ||
| Q2 25 | $159.9M | $21.3B | ||
| Q1 25 | $178.1M | $19.9B | ||
| Q4 24 | $144.2M | $18.3B | ||
| Q3 24 | $127.1M | $18.4B | ||
| Q2 24 | $145.7M | $16.5B | ||
| Q1 24 | $164.6M | $15.1B |
负债/权益比FBIORWT
| Q4 25 | 1.05× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 2.53× | — | ||
| Q4 24 | 2.55× | — | ||
| Q3 24 | 2.48× | — | ||
| Q2 24 | 3.75× | — | ||
| Q1 24 | 2.67× | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-12.5M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FBIORWT
| Q4 25 | $-12.5M | $-10.1B | ||
| Q3 25 | $-6.1M | $-2.7B | ||
| Q2 25 | $-27.6M | $-2.1B | ||
| Q1 25 | $-19.6M | $-2.0B | ||
| Q4 24 | $-12.9M | $-5.9B | ||
| Q3 24 | $-20.1M | $-2.1B | ||
| Q2 24 | $-21.8M | $-2.0B | ||
| Q1 24 | $-25.4M | $-954.2M |
资本支出强度FBIORWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率FBIORWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | -1.04× | — | ||
| Q2 25 | -1.78× | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | — | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
